The CD45 protein tyrosine phosphatase is expressed in different isofor
ms that result from alternative splicing of three exons (A, B, and C)
encoding regions near the N-terminus of the extracellular part of the
molecule, We describe here a novel epitope on the N-terminal end of CD
45 that is recognized by the MAb BL-TSub/2. Crossblocking studies show
ed that BL-TSub/2 and UCHL1 (CD45RO) binding sites are partially overl
apping. However, in marked contrast to the CD45RO epitope, protease tr
eatment of cells strongly diminished BL-TSub/2 binding, Similar to the
UCHL1 epitope, the BL-TSub/2 binding site involves carbohydrate moiet
ies, since neuraminidase treatment abrogated the reactivity of the MAb
, Markedly, preincubation of cells with both CD45 common and CD45RA MA
b induced a pronounced increase of BL-TSub/2 binding, This latter find
ing suggests that crosslinking of the CD45 molecule leads to conformat
ional changes that could influence association of the molecule with pu
tative ligands.